best pediatrician doctor in wadgaon sheri
.

๐Ÿฆ  What is Hepatitis B?

Hepatitis B is a viral infection caused by the Hepatitis B virus (HBV) that primarily affects the liver.

Transmission: Blood, sexual contact, perinatally (from mother to baby at birth), sharing needles, etc.

Virus type: DNA virus (Hepadnaviridae family)

Incubation period: 1โ€“4 months

๐Ÿ” Modes of Transmission
Route Description
Vertical Mother to child (most common in pregnancy)
Horizontal Blood products, sexual contact, needle use
๐Ÿ” Clinical Phases

Acute Hepatitis B

Often asymptomatic

Symptoms (if present): fatigue, nausea, jaundice, dark urine, RUQ pain

May resolve or progress to chronic infection

Chronic Hepatitis B

Persistence of HBsAg 6 months

Risk of cirrhosis, liver failure, and hepatocellular carcinoma (HCC)

๐Ÿงช Serology Markers
Marker Interpretation
HBsAg Active infection (acute or chronic)
Anti-HBs Immunity (from vaccine or past infection)
Anti-HBc Exposure to virus (IgM = recent; IgG = past)
HBeAg High infectivity
HBV DNA Viral load โ€“ used to guide treatment
๐Ÿคฐ Hepatitis B in Pregnancy
Key Concerns:

Mother-to-child transmission (MTCT) is the most common mode in endemic areas.

Transmission risk:

90% if mother is HBeAg+

10โ€“30% if HBeAg-

Prevention of MTCT:

Screen all pregnant women for HBsAg during first prenatal visit.

If mother is HBsAg positive:

Infant should receive:

HBV vaccine + Hepatitis B immunoglobulin (HBIG) within 12 hours of birth

Continue vaccine series at 1 and 6 months

If mother has high viral load (200,000 IU/mL):

Start antiviral therapy (e.g., Tenofovir) at 28โ€“32 weeks gestation

๐Ÿ’Š Treatment Overview
In pregnancy:

Tenofovir disoproxil fumarate (TDF) is preferred โ€“ safe and effective

Monitor liver function tests (LFTs) and HBV DNA levels

In non-pregnant adults:

Tenofovir, entecavir, pegylated interferon (not for pregnancy)

๐Ÿšจ Complications of Chronic Hepatitis B

Liver cirrhosis

Hepatocellular carcinoma

Liver failure

Portal hypertension

Variceal bleeding

โœ… Summary
Aspect Key Points
Screening All pregnant women: HBsAg at first prenatal visit
Prevention in baby HBV vaccine + HBIG within 12 hrs of birth
Antivirals in mom Tenofovir if HBV DNA 200,000 IU/mL
Breastfeeding Safe if baby received vaccine + HBIG
Long-term monitoring For chronic HBV: liver function and HCC screening

Would you like a slide format, table format, or a printable study sheet for this?
Feb 23rd, 2026 9:33 PM

Keywords